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Hexose-6-phosphate dehydrogenase (H6PD) is thought to be the major
source of NADPH within the endoplasmic reticulum (ER), determining 11b-
hydroxysteroid dehydrogenase 1 (11b-HSD1) reaction direction to convert
inert 11-oxo- to potent 11b-hydroxyglucocorticoids. Here, we tested the
hypothesis whether H6pd knock-out (KO) in primary murine bone marrow-
derived macrophages results in a switch from 11b-HSD1 oxoreduction to
dehydrogenation, thereby inactivating glucocorticoids (GC) and affecting
macrophage phenotypic activation as well as causing a more aggressive M1
macrophage phenotype. H6pd KO did not lead to major disturbances of
macrophage activation state, although a slightly more pronounced M1 phe-
notype was observed with enhanced proinflammatory cytokine release, an
effect explained by the decreased 11b-HSD1-dependent GC activation.
Unexpectedly, ablation of H6pd did not switch 11b-HSD1 reaction direction.
A moderately decreased 11b-HSD1 oxoreduction activity by 40–50% was
observed in H6pd KO M1 macrophages but dehydrogenation activity was
undetectable, providing strong evidence for the existence of an alternative
source of NADPH in the ER. H6pd KO M1 activated macrophages showed
decreased phagocytic activity, most likely a result of the reduced 11b-HSD1-
dependent GC activation. Other general macrophage functions reported to
be influenced by GC, such as nitrite production and cholesterol efflux, were
altered negligibly or not at all. Importantly, assessment of energy metabolism
using an extracellular flux analyzer and lactate measurements revealed
reduced overall glucose consumption in H6pd KO M1 activated macro-
phages, an effect that was GC independent. The GC-independent influence
of H6PD on energy metabolism and the characterization of the alternative
source of NADPH in the ER warrant further investigations.
Enzymes
11b-HSD1, EC 1.1.1.146; H6PD, EC 1.1.1.47.
Abbreviations
11-DHC, 11-dehydrocorticosterone; 11b-HSD1, 11b-hydroxysteroid dehydrogenase 1; BMDM, bone marrow-derived macrophages; CORT,
corticosterone; DMEM, Dulbecco’s modified eagle’s medium; ECAR, extracellular acidification rate; ER, endoplasmic reticulum; G6P,
glucose-6-phosphate; GC, glucocorticoid; GR, glucocorticoid receptor; H6PD, hexose-6-phosphate dehydrogenase; IFNc, interferon-c; IL,
interleukin; iNOS, inducible nitric oxidase; KO, knock-out; LPS, lipopolysaccharide; MCP-1, monocyte chemoattractant protein-1; OCR,
oxygen consumption rate; TNF-a, tumor necrosis factor-a; UHPLC–MS/MS, ultra-high-performance liquid chromatography–tandem mass
spectrometry; WT, wild-type.
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Introduction
Glucocorticoids (GC) essentially regulate major physi-
ological functions, with potent modulatory effects on
the immune system [1]. Besides the adrenal GC synthe-
sis, the tissue- and cell-specific interconversion of
active 11b-hydroxy GC [cortisol in human, corticos-
terone (CORT) in rodents] and inactive 11-oxo GC
[cortisone in human, 11-dehydrocorticosterone (11-
DHC) in rodents] by 11b-HSD enzymes plays an
important role in mediating GC effects [2]. Two iso-
zymes are known, 11b-HSD2 converts 11b-hydroxy to
11-oxo GC and 11b-HSD1 catalyzes in vivo the reverse
reaction. 11b-HSD1 is a bidirectional enzyme facing
the endoplasmic reticulum (ER) lumen, where it inter-
acts with hexose-6-phosphate dehydrogenase (H6PD)
[3–6]. H6PD utilizes glucose-6-phosphate (G6P) to
produce NADPH in the ER [7,8]. As the ER mem-
brane is not permeable for pyridine nucleotides, the
intraluminal regeneration of NADPH by H6PD deter-
mines 11b-HSD1 to predominantly catalyze the oxore-
duction of 11-oxo GC [4,9]. Upon disruption of the
cell membrane in homogenized cells or tissue, the
intraluminal NADPH is rapidly metabolized and in
the absence of G6P this results in a loss of oxoreduc-
tion activity. A switch from oxoreduction to dehydro-
genation activity was observed when comparing
11b-HSD1 activity in liver microsomes of wild-type
(WT) and H6pd knock-out (KO) mice, and the urinary
excretion revealed a dramatic shift in the 11-oxo/11b-
hydroxy GC ratio [10]. H6PD is currently the only
well characterized enzyme within the ER that gener-
ates NADPH and it is thought to be responsible for
maintaining a high luminal NADPH/NADP+ ratio.
Therefore, we anticipated that in cells from H6pd KO
mice 11b-HSD1 would catalyze predominantly the
dehydrogenation reaction, thereby inactivating GC.
Glucocorticoids affect cells of the immune system
and impact gene expression, enzymatic activity, and
cellular differentiation and migration [11]. GC are, for
example, crucial for T-cell selection by regulating
apoptosis. In macrophages, they play a pivotal but not
yet fully elucidated role in the phenotypic activation
[12], and they suppress the expression and secretion of
proinflammatory cytokines such as interleukin-1b (IL-
1b), interleukin-6 (IL-6), interferon-c (IFNc), and
tumor necrosis factor-a (TNF-a), thereby preventing
an overshooting immune response [13–16]. Blood
monocytes, derived from bone marrow progenitor
cells, are constantly patrolling the blood vessels, fulfill-
ing various functions in both innate and adaptive
immunity. If activated by tissue damage or infection,
they enter the affected tissue and undergo phenotypic
activation. Depending on the type of activator, the
classically activated M1 and the alternatively activated
M2 macrophages are distinguished. IFNc, TNF-a, or
lipopolysaccharide (LPS) induce a M1 phenotype pro-
ducing proinflammatory cytokines and bactericidal
mediators, whereas interleukin-4 (IL-4) or interleukin-
13 (IL-13) result in an M2 phenotype contributing to
the downregulation of inflammation and elimination
of tissue debris [17–21].
The expression of 11b-HSD1 in patrolling mono-
cytes is absent or very low, but strongly induced upon
activation toward a M1 phenotype [22]. It has been
shown that 11b-HSD1 is regulated dynamically during
an ongoing inflammation, which is crucial for a con-
trolled and rapid resolution of inflammation since GC
restrain the M1 activated macrophages and promote a
M2 phenotype [23,24]. Additionally, an increased 11b-
HSD1 oxoreduction activity was hypothesized to cause
a re-routing of the H6PD substrate G6P toward the
ER, causing a change in overall glucose metabolism
that has been shown to alter macrophage polarization
[25,26].
In the present study, we investigated whether in
bone marrow-derived macrophages (BMDM) from
H6pd KO mice 11b-HSD1 would predominantly func-
tion as a dehydrogenase, thereby inactivating GC and
resulting in enhanced expression of proinflammatory
cytokines. Furthermore, we tested whether the
decreased 11b-HSD1-dependent GC activation due to
absence of H6PD activity would affect the activation
of macrophage phenotypes and their functions. We
found that ablation of H6pd did not cause a loss of
GC activation by 11b-HSD1 but only a reduction by
40–50%, which translated into a decreased suppression
by 11-DHC of proinflammatory cytokine expression.
General macrophage functions were only moderately
influenced and the H6pd KO only led to slightly exag-
gerated M1 activation state with a marginally
increased proinflammatory cytokine release. However,
the KO of H6pd did cause an overall increased glucose
consumption and lactate secretion, most likely by a
GC-independent mechanism.
Results
Decreased glucocorticoid activation in H6pd KO
M1 macrophages
Based on earlier observation of an almost complete
loss of 11b-HSD1 oxoreduction activity in liver micro-
somes isolated from H6pd KO mice [10], we expected
a loss of the oxoreduction activity in BMDM from
H6pd KO mice and that the enzyme would
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predominantly exhibit oxidation activity. To test this
assumption, WT and H6pd KO M1 macrophages were
incubated with 100 nM 11-DHC for 24 h, followed by
determination of the amount of CORT released into
the medium by ultra-high-performance liquid chro-
matography–tandem mass spectrometry (UHPLC-MS/
MS). Surprisingly, compared to WT, H6pd KO macro-
phages still retained 50–60% of the oxoreduction
activity (Fig. 1A). Treatment of the macrophages with
the 11b-HSD1 inhibitor BNW16 [27] fully abolished
the oxoreduction activity in both WT and H6pd KO
macrophages, confirming that this activity was indeed
11b-HSD1-specific.
Diminished suppressive effect of 11-DHC on
proinflammatory cytokine expression in H6pd KO
M1 macrophages
To assess the functional impact of the altered 11b-
HSD1 activity, macrophages were activated toward an
M1 phenotype for 24 h followed by 24 h incubation
with increasing concentrations of 11-DHC, which
requires oxoreduction by 11b-HSD1 to CORT in order
to exert a suppressive effect on the expression of
proinflammatory cytokines. Hence, the decrease in
proinflammatory cytokine mRNA expression can serve
as a functional readout of the 11b-HSD1 oxoreduction
activity. Unlike initially anticipated, only moderate
effects were observed in the H6pd KO macrophages.
While treatment with 11-DHC suppressed the expres-
sion of all four cytokines measured, only Mcp-1 and
Il-1b mRNA expression in WT macrophages tended to
show a more pronounced decrease at 100 and 1000 nM
11-DHC compared with H6pd KO macrophages, in
line with higher 11b-HSD1 oxoreduction activity in
WT macrophages (Fig. 1B,C). Preincubation of cells
for 24 h with 100 nM 11-DHC followed by activation
into M1 phenotype with LPS+IFNc did not result in
significant changes of Il1-b, Mcp1, Il-6, and Tnfa
mRNA expression when comparing either pretreated
WT and KO cells or when comparing pretreated and
untreated cells at 1, 2, 4, 8, or 24 h after stimulation
(data not shown).
Impact of H6pd KO on macrophage phenotypes
To examine whether the observed difference in 11b-
HSD1 activity and the reduced ability of the H6pd
KO macrophages to decrease proinflammatory mark-
ers has an impact on macrophage phenotypic
Fig. 1. Conversion of 11-DHC to CORT in WT and H6pd KO macrophages and effect on proinflammatory cytokine expression. (A) M1
polarized macrophages from WT and H6pd KO mice were incubated with 100 nM 11-DHC for 24 h and formation of CORT was determined
in the supernatants by UHPLC-MS/MS. 11b-HSD1 was inhibited by 1 h preincubation with 1 lM BNW16. H6pd KO macrophages retained
50–60% 11b-HSD1 oxoreduction activity and inhibition of 11b-HSD1 completely abolished the formation of CORT in both WT and H6pd KO
macrophages (mean  SD from two animals performed in quadruplicates). Data were analyzed using the Shapiro–Wilk normality test and
unpaired t-test (B, C) After 24 h of M1 phenotypic activation, WT and H6pd KO macrophages were treated with increasing concentrations
of 11-DHC for 24 h and expression of proinflammatory markers was measured by real-time PCR. mRNA expression of Mcp-1 (B) and Il-1b
(C) showed a significant larger decrease in WT than in H6pd KO macrophages at 100 and 1000 nM and a trend at 10 nM. Results were
normalized to the house-keeping gene Ppia and reported as fold change compared to control (mean  SD of 2 WT and 3 KO animals
performed in duplicates). (B, C) Data were analyzed using the Shapiro–Wilk test and the Kruskal–Wallis test followed by the Dunn’s
posttest. CORT; 11-DHC; N.D. (not detectable); ****P < 0.0001.
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activation, the mRNA expression levels of phenotype-
specific marker genes and other genes of interest were
qualitatively assessed in M0, M1, and M2-polarized
macrophages from 8- to 12-week-old mice by real-time
PCR. Besides H6pd, which is clearly expressed in WT
but not H6pd KO macrophages, the phenotype mark-
ers indicated a trend toward a more pronounced M1
phenotype in H6pd KO macrophages (Fig. 2A). The
overall phenotypic activation seemed to be maintained;
the M1 macrophages highly expressed all M1-specific
markers, for example, iNos, Mcp1, Il1-b, Tnfa, and Il-
6, whereas the M2 macrophages expressed M2-specific
markers such as Cd206, Ym1, and Fizz1. This shows
that the absence of H6pd had only a minor impact on
macrophage phenotypic activation. The glucocorticoid
receptor (GR) was highly expressed in all phenotypes,
whereas 11b-hsd1 mRNA was upregulated in the M1
activation state but hardly expressed in M0 and M2
macrophages. Therefore, further experiments focused
on M1 activated macrophages.
Fig. 2. Confirmation of general phenotypes and comparison of M1 polarization in WT and H6pd KO macrophages. (A) For a qualitative
assessment, the mRNA expression of various markers of M1 and M2 activation state were analyzed in M0, M1 and M2 macrophages
isolated from 8- to 12-week-old WT and H6pd KO mice using real-time PCR. For each gene, the spot area is directly proportional to the fold
change in mRNA abundance compared to the WT M0 macrophages. The largest spot (highest expression) in each row was set to a fixed
arbitrary size. The absence of H6pd did not cause major changes in macrophage phenotypic activation (mean of 5–8 KO mice and 5–8 WT
mice). (B–E) Macrophages 6 WT and 6 H6pd KO mice were activated toward a M1 phenotype and expression of M1-specific mRNA
markers were measured after 1, 2, 4, and 8 h using real-time PCR. (F) Cytokines in the supernatant were measured after 4 h of M1
phenotypic induction using ELISA. The absence of H6pd caused significantly increased secretion of TNFa, IL-6 and MCP-1 protein
(mean  SD of 2 WT and 3 KO animals measured in duplicates). (B-F) Data were analyzed using the Shapiro–Wilk normality test and one-
way ANOVA. N.D. (not detectable); **P < 0.01; ***P < 0.001; ****P < 0.0001.
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A time-course covering the initial burst phase was per-
formed in WT and H6pd KOM1 macrophages and their
M1 marker expression levels were compared at different
time-points (Fig. 2B–E). Although Tnfa and Il-1b
mRNA expression levels showed a trend toward
increased expression in H6pd KO compared to WT
macrophages, they were not significantly altered at any
time point. Similar results were obtained when compar-
ing non-elicited peritoneal macrophages isolated from
WT and H6pd KO mice activated toward an M1 pheno-
type, where only Tnfa showed a trend toward an increase
inH6pdKO compared to WT (data not shown).
To assess the biological relevance of the observed
trends in some M1 markers, secreted protein levels
were measured. Therefore, M0 cells were incubated
with LPS and IFNc for 4 h to induce the M1 activa-
tion state, followed by analysis of cell supernatants by
ELISA. This revealed an approximately 1.4-fold higher
secretion of monocyte chemoattractant protein-1
(MCP-1), IL-6 and TNFa proteins in H6pd KO com-
pared to WT macrophages (Fig. 2F).
Impact of H6pd KO on general properties of M1
macrophages
Next, the impact of H6pd KO on typical M1 macro-
phage functions, such as phagocytosis, nitrite produc-
tion, and cholesterol efflux, was examined. Nitrite
production, mainly mediated by the inducible nitric
oxidase (iNOS), was measured using the Griess assay.
No nitrite production could be detected in super-
natants of M0 and M2 cells, which is in agreement
with the background levels of iNos mRNA expression
in these phenotypes; however, it was well detectable in
M1 macrophages, with a small but statistically signifi-
cant decrease in H6pd KO cells (Fig. 3A). The
Fig. 3. Comparison of general functions in WT and H6pd KO macrophages. (A) Production of nitrite was measured using Griess reagent in
supernatants of M0, M1, and M2 macrophages following 48 h of incubation. H6pd KO M1 macrophages showed a slightly decreased nitrite
production compared to WT cells, whereas nitrite production was not detectable in supernatants of M0 or M2 macrophages. (B)
Fluorescent microscopy picture of phagocytosis of opsonized latex beads by M1 macrophages. (C) Comparison of phagocytotic activity in
WT and H6pd KO M1 macrophages. Cells were incubated for 10 min with IgG ALEXA-594 labeled beads and fixed with paraformaldehyde.
Nuclei were stained with Hoechst-33342 (blue) and external beads were labelled with IgG ALEXA-488 (green). Phagocytic activity of M1
macrophages from WT and H6pd KO mice was assessed as the number of beads per 100 cells from pictures taken of each well. Scale bar:
20 lm. (D) Assessment of cholesterol efflux by WT and H6pd KO macrophages. M0, M1, and M2 macrophages were incubated with [3H]-
cholesterol for 48 h. Upon equilibration, cholesterol efflux was determined after 4 h by analyzing [3H]-cholesterol in supernatants and cells
by liquid scintillation counting. The percentage of efflux was calculated as fraction of [3H]-cholesterol in supernatant compared to that of
medium plus cells. Data represent mean  SD from three animals, performed in triplicates (A, C), analyzed by the Shapiro–Wilk and
unpaired t-test, or mean  SD of four measurements (D) analyzed by the Shapiro–Wilk and Kruskal–Wallis test followed by the Dunn’s
posttest. N.D. (not detectable), *P < 0.05.
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assessment of the phagocytic activity, a key function
of macrophages, by counting the number of IgG opso-
nized latex beads taken up by 100 cells during the
10 min incubation period (Fig. 3B), revealed a signifi-
cantly reduced phagocytic index in H6pd KO M1
macrophages (Fig. 3C). Cholesterol efflux, another
important function of macrophages, was measured in
all phenotypes using [3H]-cholesterol and was calcu-
lated as the percentage of radioactivity in the medium
from total radioactivity in medium plus cells. No dif-
ference could be detected between WT and H6pd KO
macrophages (Fig. 3D). Thus, H6pd KO decreased
phagocytic activity and had a modest effect on nitrite
production, but did not affect cholesterol efflux.
Decreased glycolytic capacity in H6pd-deficient
M1 macrophages
To investigate whether H6pd deficiency affects meta-
bolic parameters that affect macrophage function, a
glycolysis stress test was performed using a Seahorse
XFp analyzer. Thereby, compounds targeting key ele-
ments of cellular metabolism are sequentially added
at indicated time points. In the first injection, glucose
was added as an energy source. Next, oxidative phos-
phorylation in the mitochondria was shut down by
adding oligomycin and forcing the cells to cover their
energy demand exclusively by glycolysis. Finally, 2-
deoxyglucose was added to inhibit glycolysis by
blocking glucose hexokinase and verifying glycolysis
as a major source of the previously measured basal
extracellular acidification rate (ECAR). During this
procedure, the ECAR and oxygen consumption rate
(OCR) are measured in a transient microchamber.
The ECAR measurements showed a decreased base-
line glycolytic activity in H6pd KO compared to WT
M1 macrophages (Fig. 4A–C). In both WT and H6pd
KO macrophages, the glycolytic reserve, indicated by
the increase in ECAR upon addition of oligomycin,
was low, pointing toward a negligible role of mito-
chondrial energy production. The OCR was also
lower in H6pd KO compared to WT M1 macro-
phages under glucose deprivation (Fig. 4D–F). This
difference was less pronounced upon addition of glu-
cose, whereby the H6pd KO macrophages seemed to
have lost the responsiveness to glucose addition. The
nonresponsiveness in the OCR measurements is char-
acteristic of M1 activated macrophages and represents
a state of inhibited mitochondrial oxidative respira-
tion [28]. To confirm the decreased acidification rates
of the H6pd KO macrophages measured in the Sea-
horse analyzer by another approach, lactate levels
were determined using a colorimetric assay kit. M0
macrophages of WT and H6pd KO were activated
toward an M1 phenotype while supernatant samples
were taken at 4, 24, and 48 h. The amount of lactate
produced in H6pd KO macrophages showed a weak
trend toward a decrease after 24 h, which became sig-
nificant after 48 h (Fig. 4G).
Discussion
In this study, we showed that the loss of H6pd in
macrophages unexpectedly did not abolish 11b-HSD1-
dependent conversion of 11-DHC to CORT but
resulted in a rather moderate decrease of oxoreduction
activity of only 40–50%. Dehydrogenation activity
could neither be detected in intact WT nor in H6pd
KO macrophages. The fact that there is no switch
from 11-oxoreduction to dehydrogenation in H6pd
KO macrophages as well as the moderate decrease in
oxoreduction activity is surprising and might be
explained by a compensatory adaptation involving a
yet unknown NADPH generating system in the ER.
Results from HEK-293 cells transfected with H6pd
compared to mock transfected cells and data from
HT-1080 connective tissue cells where H6pd was
knocked down using siRNA showed a switch from
11b-HSD1 oxoreduction to dehydrogenation activity
when H6pd was absent or knocked down [3,4,29].
These cell types might not express the alternative
NADPH generating system present in the ER of
macrophages. Also, studies with liver microsomes from
H6pd KO mice showed an almost complete loss of
oxoreduction but high dehydrogenation activity [10].
Notably, NADPH is not freely passing the ER mem-
brane and during preparation of microsomes, the
NADPH in the luminal compartment is used up
because of the absence of the substrate for the luminal
NADPH regenerating system (i.e. G6P for H6PD or
the substrate of the yet unknown luminal regenerating
system).
Currently, H6PD represents the only well character-
ized enzyme generating NADPH in the ER and based
on the observation of an almost complete loss of 11b-
HSD1 oxoreduction activity in liver microsomes from
H6pd KO mice it was suggested that H6PD is the
major source of NADPH within the ER [10]. Our
observation of a rather moderate effect of H6pd KO
on 11b-HSD1 oxoreduction activity in intact macro-
phages indicates the existence of an alternative yet less
efficient source for NADPH in the ER of these cells.
The distinct effect of H6PD deficiency in macrophage,
HT-1080 and HEK-293 cells suggests a cell-type speci-
fic expression of such an alternative NADPH regener-
ating system in the ER.
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Earlier work provided evidence for the existence of
a pentose phosphate pathway in the ER [30], whereby
H6PD was shown to catalyze the first two steps of this
pathway, converting G6P to 6-phosphogluconate [31].
There is evidence from work on liver microsomes for
the existence of a 6-phosphogluconate dehydrogenase
in the ER that produces NADPH ([32,33], own obser-
vations); however, the corresponding gene remains to
be identified. Nevertheless, as 6-phosphogluconate is
not freely permeable across the ER membrane, this
enzyme unlikely accounts for the observed remaining
11b-HSD1-dependent oxoreduction activity. The
unknown source of NADPH in the ER needs to be
uncovered, and H6pd KO macrophages constitute an
interesting model for studying such mechanisms.
Interestingly, the absence of H6pd did not grossly
interfere with macrophage activation into M1 and M2
phenotypes. Due to the moderate effect of H6pd KO
on 11b-HSD1 oxoreduction activity, the M1 pheno-
type was barely affected, with only weak trends toward
an increased expression of some M1 markers and an
approximately 1.4-fold increased release of proinflam-
matory cytokines, most likely because of lower pro-
duction of active GC. Considering the great
Fig. 4. Assessment of metabolic
parameters of WT and H6pd KO M1
macrophages. Basal ECAR, A–C) and
oxidation consumption rates (OCR, D–F)
were recorded in a Seahorse XFp
Extracellular Flux Analyzer, followed by the
sequential addition of 10 mM glucose, 1 lM
oligomycin, and 50 mM 2-deoxyglucose (2-
DG). H6pd KO macrophages showed lower
basal ECAR and OCR and an overall
decreased ECAR (mean  SD of three
measurements). (G) M1 macrophages of
WT and H6pd KO were incubated and the
amount of lactate was measured at 4, 24
and 48 h using a colorimetric lactate assay
kit. H6PD KO macrophages showed
decreased lactate production after 48 h.
Values were normalized to protein content
(mean  SD of three animals measured in
duplicates). Data were analyzed by Shapiro–
Wilk and one-way ANOVA *P < 0.05.
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inducibility of macrophage cytokine expression and
secretion, these minor changes are unlikely to be of
biological relevance. A more strongly enhanced
release of proinflammatory cytokines was reported in
11b-HSD1-deficient mice [23,34]. Whereas M1 macro-
phages from H6pd KO mice showed comparable 11b-
HSD1 expression to WT cells, the corresponding
oxoreduction activity was reduced. This is in agree-
ment with the above-mentioned regulation of 11b-
HSD1 activity via cosubstrate availability. Thus,
regarding GC activation the alternative NADPH
source could not entirely compensate for the loss of
H6pd, resulting in a weak trend toward a more pro-
nounced M1 phenotype.
Other general macrophage functions, including
cholesterol efflux and nitrite production, were not
changed or were statistically significant but not consid-
ered biologically relevant, respectively. In the H6pd
KO macrophages, the moderate effect on 11b-HSD1
was not sufficient to affect cyclodextrin-stimulated
cholesterol efflux. This may seem surprising because in
macrophages from 11b-hsd1-deficient mice an increase
in ApoAI-stimulated cholesterol efflux was
reported [35]. A possible explanation may be that
overall cholesterol efflux was measured using cyclodex-
trin as cholesterol acceptor, which is not pathway
specific, whereas ApoAI exclusively stimulates
ABCA1-dependent efflux.
Furthermore, it was shown that GC promote phago-
cytic activity of macrophages and that the higher
phagocytic activity of macrophages upon treatment
with 11-DHC is dependent on 11b-HSD1 [23]. 11b-
HSD1 was found to promote the rapid clearance of
apoptotic leukocytes during the resolution of inflam-
mation, whereby phagocytic clearance was delayed in
macrophages from 11b-hsd1 KO mice. Whether the
observed decrease in phagocytic activity of H6pd KO
macrophages, most likely a consequence of the lower
GC activation due to the limited supply of NADPH as
11b-HSD1 substrate, results in delayed phagocytic
clearance and resolution of inflammation in vivo
remains to be investigated.
Besides its role in GC activation, H6PD may affect
other metabolic functions through catalyzing the first
two steps of the pentose phosphate pathway in the ER
[36]. The present analysis of the metabolism of M1
macrophages showed that they cover their energy
demand almost exclusively through aerobic glycolysis.
This is in agreement with the generally accepted War-
burg-like metabolism found in dendritic cells and in
macrophages upon LPS stimulation [37]. Noteworthy,
the H6pd KO macrophages showed a markedly
decreased overall glucose consumption, further
consolidated by a decreased lactate concentration in
cell supernatants. Such a decrease was also reported in
cancer cells upon knock-down of H6pd and attributed
to a H6PD-dependent glucose utilization pathway [38].
Additional support for the contribution of such a
pathway comes from the increased OCR under glucose
starvation observed in WT macrophages in the present
study. The effect of using oxygen despite being primed
for aerobic glycolysis has also been reported for T cells
under glucose-starved conditions [39]. Since the H6pd
KO macrophages show less oxygen consumption under
these conditions, they seem to be less affected by the
limited availability of glucose due to their reduced
overall glucose consumption.
In conclusion, we showed that H6pd KO does not
lead to major disturbances of macrophage phenotypic
activation and that it results in only a moderate
decrease in 11b-HSD1-mediated GC activation in M1
macrophages and not to a switch of this enzyme to
primarily catalyze the oxidation reaction. H6pd KO
M1-polarized macrophages showed only a slight trend
toward a more aggressive M1 phenotype but displayed
a significantly reduced phagocytic activity, in agree-
ment with decreased GC activation. Importantly, H6pd
KO M1 macrophages showed decreased glucose utiliza-
tion and lactate production rates, most likely by a
GC-independent mechanism. The results indicate a
modulatory role of H6PD in 11b-HSD1-dependent GC
activation as well as a GC-independent role in regulat-
ing energy metabolism.
Methods
Generation of bone marrow-derived
macrophages and activation to M1 and M2
phenotype
Bone marrow-derived macrophages were obtained from
femurs of female C57BL/6 WT and H6pd KO mice at the age
between 10 and 12 weeks as described previously [40]. The
H6pd KO mouse line was kindly provided by Gareth Lavery,
University of Birmingham, UK [10]. Mice were housed in cli-
mate-controlled facility under standard conditions on a 12 h
light/12 h dark cycle with free access to standard chow and
drinking water. The mice were sacrificed by CO2, followed
by isolation of BMDM. All procedures were approved by
the Cantonal Veterinary Office in Basel, Switzerland. After
cervical dislocation both femurs were dissected and the epi-
physes removed. The bone marrow was flushed into a 15-mL
plastic tube with 8 mL Dulbecco’s modified Eagle’s medium
(DMEM, Sigma-Aldrich, St. Louis, MO, USA) using a 25-G
needle on a syringe. Upon centrifugation at 200 9 g for
2 min the pellet was resuspended in 800 lL DMEM
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supplemented with 10% FBS (Connectorate, Dietikon,
Switzerland), 100 UmL1 penicillin, 100 lgmL1 strepto-
mycin, followed by distribution into eight 6-cm bacterial
dishes containing 5 mL of the same medium supplemented
with 10 ngmL1 macrophage colony-stimulating factor
(BioLegend, San Diego, CA, USA). Cells were then incu-
bated at 5% CO2 and 37 °C in order to induce differentia-
tion into BMDM. After 3 days, 5 mL of new medium was
added. Cells were harvested at day 7 by scraping.
Phenotypic activation of BMDM was induced by supple-
menting the differentiation medium with 100 ngmL1 LPS
and 50 ngmL1 IFNc for M1 phenotype, and 10 ngmL1
IL-4 (cytokines were from Sigma-Aldrich) for M2 pheno-
type. The incubation time was 4 h in case of cytokine secre-
tion measurements and 24 h for functional assays.
Gene expression analysis by real-time
polymerase chain reaction
Total RNA was isolated from BMDM using TRI
Reagent (Sigma-Aldrich) and purified with the Direct-zolTM
RNA MiniPrep kit (Zymo Research, Irvine, CA, USA)
according to the manufacturer’s protocol. Moloney murine
leukemia virus reverse transcriptase (M-MLV-RT, Pro-
mega, Fitchburg, WI, USA) was used for cDNA synthesis.
KAPA SYBR Fast qPCR Master Mix (KAPA Biosys-
tems, Woburn, MA, USA) was used for the RT-PCR com-
prising 40 cycles of 95 °C for 10 s, 60 °C for 15 s, followed
by a final extension at 72 °C for 20 s, and a dissociation
curve. The oligonucleotide primers (Table 1) were designed
using the IDT SciTool for real-time PCR and synthesized
by Microsynth (Balgach, Switzerland).
Quantification of steroids in cell culture
supernatants
To each culture supernatant or calibrator (100 lL) an
internal standard solution containing corticosterone-d8 in
acetonitrile (100 lL, 200 nM) was added. Proteins were pre-
cipitated by adding ice-cold acetonitrile (500 lL) and sam-
ples were incubated thoroughly shaking (20 min,
1300 r.p.m., 4 °C). Samples were centrifuged (10 min,
16 000 9 g, 4 °C). Samples were evaporated to dryness
and reconstituted in methanol (25 lL, 15 min, 1300 r.p.m.,
4 °C). CORT and 11-DHC were quantified by UHPLC–
MS/MS using an Agilent 1290 UHPLC coupled to an Agi-
lent 6490 triple quadrupole mass spectrometer essentially as
described earlier [41].
Griess assay
Free nitrite was measured in culture supernatants using
Griess reagent (Sigma-Aldrich). BMDM were seeded at a
density of 0.5 9 106 cells/well in a non-tissue culture trea-
ted 12-well plate (Starlab, Switzerland) and activated
toward M1 or M2 phenotypes or left in their unactivated
state in phenol red-free medium for 48 h. A quantity of
100 lL of supernatant was transferred in triplicates onto a
96-well plate. Then, 100 lL of Griess reagent was added,
the plate incubated for 5 min at 37 °C, followed by mea-
suring the absorbance at 540 nm. The results were normal-
ized to total protein content, determined by using the
Pierce BCA protein assay according to the manufacturer’s
protocol (Thermo Fisher Scientific, Waltham, MA, USA).
Determination of phagocytic index
The phagocytic index was determined as described previ-
ously [42]. Briefly, polystyrene latex beads with 3 lm mean
particle size (Sigma-Aldrich) were opsonized with anti-goat
IgG (Sigma-Aldrich) and labeled with donkey anti-goat
IgG ALEXA-594 (Life Technologies, Zug, Switzerland).
BMDM were seeded at a density of 0.5 9 105 cells/well on
a 96-well plate and left in M1 differentiation medium for
24 h. A quantity of 100 lL of opsonized and labeled bead-
solution was added to each well and the plate was
Table 1. Primer sequences
Forward Reverse
Ppia CAAATGCTGGACCAAACACAAACG GTTCATGCCTTCTTTCACCTTCCC
Gr TGCTATGCTTTGCTCCTGATCTG TGTCAGTTGATAAAACCGCTGCC
11b-hsd1 TGGTGCTCTTCCTGGCCTACT CCCAGTGACAATCACTTTCTTT
H6pd CTTGAAGGAGACCATAGATGCG TGATGTTGAGAGGCAGTTCC
inos ATGAGGTACTCAGCGTGCTCCA CCACAATAGTACAATACTACTT
Mcp-1 TTAAAAACCTGGATCGGAACCAA GCATTAGCTTCAGATTTACGGGT
Il-1b CAACCAACAAGTGATATTCTCCATG GATCCACACTCTCCAGCTGCA
Tnfa CTTCTGTCTACTGAACTTCGGG TGTCTTTGAGATCCATGCCG
Il-6 TCCAGTTGCCTTCTTGGGAC AGTCTCCTCTCCGGACTTGT
Cd206 CTCTGTTCAGCTATTGGACGC TGGCACTCCCAAACATAATTTGA
Ym1 GATGCAGAACAATGAGATCACC ATGGTAGTGAAAGGAGCAGTTC
Fizz1 AAGCCTACACTGTGTTTCCTTTT GCTTCCTTGATCCTTTGATCCAC
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centrifuged at 350 9 g for 1 min for synchronized settling
of beads. After 10 min at 37 °C, phagocytosis was arrested
by placing the plate on ice and washing twice with cold
medium. Remaining external particles were labelled by add-
ing donkey anti-goat IgG ALEXA-488 (Life Technologies)
for 5 min. After fixation with 4% paraformaldehyde and
staining with Hoechst-33342 (Invitrogen, Carlsbad, CA,
USA) cells were covered with PBS. Cells of five random
fields per well were manually analyzed using a Leica DMI
4000B fluorescence microscope. The phagocytic activity was
assessed as number of beads/100 cells from four indepen-
dent measurements.
Measurement of cholesterol efflux
Cholesterol efflux was measured as described previously
[43]. Briefly, BMDM were seeded at a density of
0.4 9 106 cells/well of a 12-well plate and either activated
toward an M1 or M2 phenotype or left in the M0 state.
Cells were incubated in medium containing 0.5 lCimL1
[3H]-cholesterol (PerkinElmer, Boston, MA, USA) for 48 h,
the medium was removed and cells were washed twice with
prewarmed PBS. Serum-free medium was added for 18 h to
allow equilibration of the labeled cholesterol between the
cellular compartments. Cells were washed and incubated
with new serum-free medium in the absence or presence of
1 mgmL1 cyclodextrin (Sigma-Aldrich) as a cholesterol
efflux acceptor for 4 h. The [3H]-cholesterol efflux was then
quantified by separate liquid scintillation counting of super-
natant and cell lysate and reported as the ratio of radiola-
beled cholesterol in the medium compared to that of
medium and cells.
ELISA
Bone marrow-derived macrophages were seeded at a den-
sity of 0.5 9 106 cells/well in a 12-well plate and allowed to
settle for 24 h. Then, BMDM were activated toward an
M1 phenotype for 4 h, followed by collecting supernatants,
and measuring TNFa, IL-1b, and MCP-1 levels using an
ELISA Ready-SET-Go kit according to the manufacturer’s
protocol (eBioscience, San Diego, CA, USA). The values
were normalized to total protein.
Seahorse assay
Bone marrow-derived macrophages were seeded at a den-
sity of 0.5 9 105 cell/well in a XFp plate (Agilent Technol-
ogies, Basel, Switzerland) and activated by addition of M1
medium for 24 h. Then, ECAR and OCR were measured
as suggested by the manufacturer’s protocol for the glycoly-
sis stress test (Agilent Technologies). Briefly, the activated
cells were equilibrated in XF base medium (Agilent Tech-
nologies) supplemented with 2 mM L-glutamine (Sigma-
Aldrich) and placed in a CO2-free incubator at 37 °C for
1 h prior to the assay. Then, glucose, oligomycin and 2-
deoxyglucose (contained in the kit) were sequentially
injected in that order during continuous oxygen and H+
measurements. Data were normalized to cell protein con-
tent.
Lactate assay
Lactate was determined in supernatants of M1 macro-
phages cultured in a 12-well plate at a density of
0.5 9 106 cells/well. Supernatants were collected by snap-
freezing 50 lL of sample at each time-point. The samples
were measured using the L-lactate assay (Abcam,
Cambridge, UK) according to the manufacturer’s protocol.
Results were normalized to total protein.
Statistical analysis
Statistical analyses were conducted using GRAPHPAD PRISM
5.0 software. To analyze the difference between WT and
KO, first, the normal distribution of the data was deter-
mined using the Shapiro–Wilk normality test. For nonpara-
metric distributed data, the Kruskal–Wallis test followed
by the Dunn’s posttest was applied. Parametric distributed
data were analyzed using an unpaired t-test or one-way
ANOVA. Values represent mean  SD.
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